KALARIS THERAPEUTICS INC

Historical 13F Holders

Symbol
KLRS
CUSIP
482929106
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 482929106 since 12/18/2024, largest first.

Filer % of Class Filed
Samsara BioCapital, L.P. 13D/A
54.2% 5/22/2026
Event 5/20/2026
RTW Investments, LP 13G
5.7% 2/17/2026
Event 12/31/2025
Coastlands Capital LP 13G
5.7% 10/26/2026
Event 10/19/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Gilead Sciences, Inc. 13G/A 3.9% 3/20/2025
Event 3/18/2025
Invus Global Management, LLC 13G/A
1.5% 7/29/2025
Event 6/30/2025
EcoR1 Capital, LLC 13G/A
1.1% 5/15/2025
Event 3/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 54 17.2 M $49.8M
2026 Q2 56 18.0 M $73.4M
2026 Q1 58 18.7 M $108M
2025 Q4 51 18.0 M $152M
2025 Q3 32 13.2 M $76.4M
2025 Q2 31 13.4 M $35.7M
2025 Q1 33 13.9 M $111M